Mort Kondracke Quotes

Once an effective drug is approved to treat a deadly condition, introducing a second drug to treat the same disease can be hard. It's tough to recruit patients with a debilitating disease for a clinical trial when a proven medicine is already available.

Scientists have established huge numbers of links between particular diseases and snippets of DNA, but in the great majority of cases, this has not yet been translated into treatments that can help cure patients. These treatments will come - tomorrow, or the day after.

You can have a very bad end with Parkinson's, but on the other hand, you can be like me, because I'm lucky. I'm not having a bad end.

I can't say when we will have a cure, but we now know through our findings how to ask the question of what is going wrong at the earliest stage of Alzheimer's.

When you immerse yourself in medicine you realise that hope is not absolute. It's not that simple.

Now, what tends to happen is that the stories get hyped. And the medicines are not quite as revolutionary and as dramatic as they seem to be. But, certainly, various phases of this problem are being attacked by the pharmaceutical companies.

In a prime-time address, President Bush said he backed limited federal funding for stem cell research. That's right, the President said, this is a quote, the research could help cure brain diseases like Alzheimer's, Parkinson's, and whatever it is I have.

I think eventually they're going to find out that MS is like 10 different things. I have a neurological disease something like MS, and it's MS, so let's take medicine for it.

As a practicing neurologist, I can tell you first hand that working with Parkinson's patients offers clinical challenges. But from an emotional perspective, this disease can border on overwhelming.

What sense would it make or what would it benfit a physician if he discovered the origin of the diseases but could not cure or alleviate them?

Affordability is critical so that patients have access to medicines. At the same time, it's also important that we have the kind of incentives that allow us to do the kinds of studies that we need to do to go after these diseases like Alzheimer's.

We'll be investing in basic science research with the goal of curing disease.

If we can validate our scientific bets in the clinic, if we can bring valuable new treatments to patients that need them, that will be our ultimate measure of success.

If you sit in a position where decisions that you take would have a serious effect on people, you can't ignore a lot of experience around the world which says this drug has these negative effects.

Paradoxically, no such embargo exists for the drugs and therapies that have revolutionized the treatment of serious diseases although many of them were created with the same technologies.

Stem cells are probably going to be extremely useful.

Investigating rare diseases gives researchers more clues about how the healthy immune system functions.

Drug discovery is terribly expensive, just to find out how one drug could or could not work and all its side effects.

Dedicated researchers seek better treatments and cures for diabetes, kidney disease, Alzheimer's and every form of cancer. But these scientists face an array of disincentives. We can do better.

New drugs and surgical techniques offer promise in the fight against cancer, Alzheimer's, tuberculosis, AIDS, and a host of other life-threatening diseases. Animal research has been, and continues to be, fundamental to advancements in medicine.

My job is to stay alive until the medicine and research catch up.

About six years ago my family was affected by multiple sclerosis.

And there are lots of drug companies that are working on cure or medicine.

Lipitor is one of the most researched medicines. I'm glad I take Lipitor, as a doctor, and a dad.

I think that research is incredibly important and hopefully one day there will be a cure for cancer. They are making great strides.